NUCLEIX
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
NUCLEIX
Industry:
Biotechnology Health Care Information Technology Manufacturing Medical Device Personal Health
Founded:
2008-01-01
Address:
Rehovot, HaMerkaz, Israel
Country:
Israel
Website Url:
http://www.nucleix.com
Total Employee:
11+
Status:
Active
Contact:
+97289161616
Email Addresses:
[email protected]
Total Funding:
82.99 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Apache
Similar Organizations
Angeion Corporation
Angeion Corp develops, manufactures and markets non-invasive cardiorespiratory diagnostic systems.
CROSSWAY
CROSSWAY develops and manufactures physical fitness diagnostic systems and measuring devices.
eWAVE
eWAVE develops, manufactures, and markets optical transport systems.
Norman Biological Technology
Norman Biological Technology is a manufacturer of automated chemiluminescence system.
Current Advisors List
Current Employees Featured
Founder
Investors List
Zohar Zisapel
Zohar Zisapel investment in Venture Round - Nucleix
RA Capital Management
RA Capital Management investment in Venture Round - Nucleix
Sands Capital Ventures
Sands Capital Ventures investment in Venture Round - Nucleix
OrbiMed
OrbiMed investment in Venture Round - Nucleix
OCI Bio Investments
OCI Bio Investments investment in Venture Round - Nucleix
BlackRock
BlackRock investment in Venture Round - Nucleix
DSC Investment
DSC Investment investment in Venture Round - Nucleix
RA Capital Management
RA Capital Management investment in Venture Round - Nucleix
OrbiMed
OrbiMed investment in Venture Round - Nucleix
MILFAM
MILFAM investment in Venture Round - Nucleix
Official Site Inspections
http://www.nucleix.com Semrush global rank: 9.84 M Semrush visits lastest month: 95
- Host name: 172.67.70.11
- IP address: 172.67.70.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nucleix"
Nucleix – Company
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based …See details»
Nucleix Ltd. - LinkedIn
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging PCR-based ...See details»
Nucleix - Crunchbase Company Profile & Funding
Nucleix develops, manufactures, and markets non-invasive molecular cancer …See details»
Nucleix Company Profile - Office Locations, Competitors ... - Craft
Nucleix has 5 employees across 2 locations and $60.97 m in total funding,. See insights on Nucleix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Nucleix - Org Chart, Teams, Culture & Jobs | The Org
View Nucleix's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Nucleix - Israeli Startup | Startup Nation Finder
Mar 16, 2022 Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. …See details»
Nucleix 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Nucleix. Use the PitchBook Platform to explore the full profile.See details»
Nucleix – About Us
About Us Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest …See details»
Nucleix Ltd. - LinkedIn
Nucleix Ltd. | 6,987 followers on LinkedIn. Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the …See details»
Nucleix Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Jun 23, 2025 Explore Nucleix Ltd. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 21 news, and 5 literature.See details»
Nucleix Org Chart + Executive Team - The Official Board
The org chart of Nucleix contains its 21 main executives like Chris Hibberd and Todd Myers.See details»
Nucleix
Nucleix’s Bladder EpiCheck® Receives FDA 510 (k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence READ MORESee details»
Nucleix | StartupHub.ai
Nucleix is a healthcare startup founded in 2008 that specializes in liquid biopsy for early-stage and recurring cancer detection. They use methylation-based identification and their non-invasive …See details»
Nucleix - The Org
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic biomarkers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products …See details»
Nucleix Ltd. - VentureRadar
"Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection, at a time when intervention can bring the greatest impact for patients. Leveraging …See details»
Nucleix – Careers
US OFFICE Phone +1-858-283-3398 10675 Sorrento Valley Road, Ste 250, San Diego, CA 92121See details»
Nucleix – Technology
Nucleix was built around DNA methylation expertise, and we were the first to develop a methylation-based tissue identification assay 1,2. The EpiCheck assay determines the …See details»
Nucleix - Profiles & Contacts - Crunchbase
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.See details»
Nucleix – News&Events
May 6, 2024 Nucleix to Present Data Showcasing Performance and Clinical Utility of Bladder EpiCheck® Monitoring in Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence at AUA …See details»
Nucleix – Videos
The role of biomarkers in the diagnostic process of bladder carcinoma. Watch the presentation of Dr. Félix Guerrero Ramos (Madrid, Spain) October 14th, 2021 The 1st virtual International …See details»